241 related articles for article (PubMed ID: 15661626)
1. Nicotine: from molecular mechanisms to behaviour.
Wonnacott S; Sidhpura N; Balfour DJ
Curr Opin Pharmacol; 2005 Feb; 5(1):53-9. PubMed ID: 15661626
[TBL] [Abstract][Full Text] [Related]
2. Nicotine activates and desensitizes midbrain dopamine neurons.
Pidoplichko VI; DeBiasi M; Williams JT; Dani JA
Nature; 1997 Nov; 390(6658):401-4. PubMed ID: 9389479
[TBL] [Abstract][Full Text] [Related]
3. Nicotinic receptors and stages of nicotine dependence.
Brennan KA; Lea RA; Fitzmaurice PS; Truman P
J Psychopharmacol; 2010 Jun; 24(6):793-808. PubMed ID: 19251827
[TBL] [Abstract][Full Text] [Related]
4. The neuronal pathways mediating the behavioral and addictive properties of nicotine.
Balfour DJ
Handb Exp Pharmacol; 2009; (192):209-33. PubMed ID: 19184651
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular mechanisms of action of nicotine in the CNS.
Barik J; Wonnacott S
Handb Exp Pharmacol; 2009; (192):173-207. PubMed ID: 19184650
[TBL] [Abstract][Full Text] [Related]
6. Nicotine addiction: insights from recent animal studies.
Mathieu-Kia AM; Kellogg SH; Butelman ER; Kreek MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):102-18. PubMed ID: 12110988
[TBL] [Abstract][Full Text] [Related]
7. Recognising nicotine: the neurobiological basis of nicotine discrimination.
Smith JW; Stolerman IP
Handb Exp Pharmacol; 2009; (192):295-333. PubMed ID: 19184654
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
[TBL] [Abstract][Full Text] [Related]
9. CB1 receptor antagonists for the treatment of nicotine addiction.
Cohen C; Kodas E; Griebel G
Pharmacol Biochem Behav; 2005 Jun; 81(2):387-95. PubMed ID: 15935455
[TBL] [Abstract][Full Text] [Related]
10. Nicotine and brain development.
Dwyer JB; Broide RS; Leslie FM
Birth Defects Res C Embryo Today; 2008 Mar; 84(1):30-44. PubMed ID: 18383130
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological, behavioral, and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain.
Abood LG; Lowy K; Tometsko A; Booth H
J Neurosci Res; 1978; 3(5-6):327-33. PubMed ID: 739555
[No Abstract] [Full Text] [Related]
12. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions.
Viveros MP; Marco EM; Llorente R; Lamota L
Behav Pharmacol; 2007 Sep; 18(5-6):375-89. PubMed ID: 17762508
[TBL] [Abstract][Full Text] [Related]
13. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.
Dursun SM; Kutcher S
Med Hypotheses; 1999 Feb; 52(2):101-9. PubMed ID: 10340289
[TBL] [Abstract][Full Text] [Related]
14. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
Jonkman S; Markou A
Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
[TBL] [Abstract][Full Text] [Related]
15. Nicotine an efficient tool of the neurobiological research today, the tool of treatment tomorrow?
Riljak V; Langmeier M
Prague Med Rep; 2005; 106(4):329-48. PubMed ID: 16572927
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and biochemical studies in rats after chronic exposure to nicotine.
Abood LG; Grassi S; Costanzo M; Junig J
NIDA Res Monogr; 1984; 54():348-55. PubMed ID: 6442761
[No Abstract] [Full Text] [Related]
17. Tobacco smoking and nicotine neuropsychopharmacology: some future research directions.
Domino EF
Neuropsychopharmacology; 1998 Jun; 18(6):456-68. PubMed ID: 9571654
[TBL] [Abstract][Full Text] [Related]
18. Modulation by nicotine on muscarinic receptor-effector systems.
Wang H
Zhongguo Yao Li Xue Bao; 1997 May; 18(3):193-7. PubMed ID: 10072930
[No Abstract] [Full Text] [Related]
19. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
[TBL] [Abstract][Full Text] [Related]
20. Neurobiology of nicotine addiction: implications for smoking cessation treatment.
Benowitz NL
Am J Med; 2008 Apr; 121(4 Suppl 1):S3-10. PubMed ID: 18342164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
